BMS-663068 50mg 50mg | Purity Not Available
Adooq Bioscience
BMS-663068 is an HIV-1 attachment inhibitor in development for the treatment of HIV-1 infection.
More Information Supplier PageBMS-663068 is an HIV-1 attachment inhibitor in development for the treatment of HIV-1 infection.
More Information Supplier PageBMS-663068 is an HIV-1 attachment inhibitor in development for the treatment of HIV-1 infection.
More Information Supplier PageBMS-663068 is an HIV-1 attachment inhibitor in development for the treatment of HIV-1 infection.
More Information Supplier PageBMN-673 (8R,9S) is the (8R,9S) enantiomer of BMN-673. BMN 673 is a novel PARP inhibitor with IC50 of 0.58 nM(PARP1).
More Information Supplier PageBMN-673 (8R,9S) is the (8R,9S) enantiomer of BMN-673. BMN 673 is a novel PARP inhibitor with IC50 of 0.58 nM(PARP1).
More Information Supplier PageBMN-673 (8R,9S) is the (8R,9S) enantiomer of BMN-673. BMN 673 is a novel PARP inhibitor with IC50 of 0.58 nM(PARP1).
More Information Supplier PageBivalirudin Trifluoroacetate is a synthetic 20 residue peptide which reversibly inhibits thrombin.
More Information Supplier PageBivalirudin Trifluoroacetate is a synthetic 20 residue peptide which reversibly inhibits thrombin.
More Information Supplier PageBMS-663068 tris is an HIV-1 attachment inhibitor in development for the treatment of HIV-1 infection.
More Information Supplier PageBMS-663068 tris is an HIV-1 attachment inhibitor in development for the treatment of HIV-1 infection.
More Information Supplier Page